Skip to main content Accessibility help

Screening for vestibular schwannoma in the context of an ageing population

  • S Basu (a1), R Youngs (a1) and A Mitchell-Innes (a2)



To review the literature regarding screening for vestibular schwannoma in the context of demographic changes leading to increasing numbers of elderly patients presenting with asymmetric auditory symptoms.


A systematic review of the literature was performed, with narrative synthesis and statistical analysis of data where appropriate.


Vestibular schwannomas diagnosed in patients aged over 70 years exhibit slower growth patterns and tend to be of smaller size compared to those tumours in younger age groups. This fact, combined with reduced life expectancy, renders the probability of these tumours in the elderly requiring active treatment with surgery or stereotactic radiotherapy to be extremely low. Vestibular schwannomas in the elderly are much more likely to be managed by serial monitoring with magnetic resonance imaging. The weighted yield of magnetic resonance imaging in the diagnosis of vestibular schwannoma in all age groups is 1.18 per cent, with almost 85 scans required to diagnose 1 tumour.


An evidence-based approach to the investigation of asymmetric hearing loss and tinnitus in the elderly patient can be used to formulate guidelines for the rational use of magnetic resonance imaging in this population.


Corresponding author

Author for correspondence: Mr Syamaprasad Basu, 1A Lonsdale Road, Gloucester GL2 0TA, UK E-mail:


Hide All

Mr S Basu takes responsibility for the integrity of the content of the paper



Hide All
1Hentschel, M, Scholte, M, Steen, S, Kunst, H, Rovers, M. The diagnostic accuracy of non-imaging screening protocols for vestibular schwannoma in patients with asymmetrical hearing loss and/or unilateral audiovestibular dysfunction: a diagnostic review and meta-analysis. Clin Otolaryngol 2017;42:815–23
2Caulley, L, Sawada, M, Hinther, K, Ko, YI, Crowther, JA, Kontorinis, G. Geographic distribution of vestibular schwannomas in West Scotland between 2000-2015. PLoS One 2017;12:e0175489
3Pew Research Center. Age breakdown of world population, 1950-2050. In: [13 June 2018]
4Gal, TJ, Shinn, J, Huang, B. Current epidemiology and management trends in acoustic neuroma. Otolaryngol Head Neck Surg 2010;142:677–81
5Stangerup, SE, Caye-Thomasen, P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am 2012;45:257–68
6Lau, T, Olivera, R, Miller, T Jr, Downes, K, Danner, C, van Loveren, HR et al. Paradoxical trends in the management of vestibular schwannoma in the United States. J Neurosurg 2012;117:514–19
7Kleijwegt, M, Ho, V, Visser, O, Godefroy, W, van der Mey, A. Real incidence of vestibular schwannoma? Estimations from a national registry. Otol Neurotol 2016;37:1411–17
8Stepanidis, K, Kessel, M, Caye-Thomasen, P, Stangerup, SE. Socio-demographic distribution of vestibular schwannomas in Denmark. Acta Otolaryngol 2014;134:551–6
9Carlson, ML, Habermann, EB, Wagie, AE, Driscoll, CL, Van Gompel, JJ, Jacob, JT et al. The changing landscape of vestibular schwannoma management in the United States - a shift toward conservatism. Otolaryngol Head Neck Surg 2015;153:440–6
10Babu, R, Sharma, R, Bagley, JH, Hatef, J, Friedman, AH, Adamson, C. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 2013;119:121–30
11Patel, J, Vasan, R, van Loveren, H, Downes, K, Agazzi, S. The changing face of acoustic neuroma management in the USA: analysis of the 1998 and 2008 patient surveys from the Acoustic Neuroma Association. Br J Neurosurg 2014;28:20–4
12Stangerup, SE, Tos, M, Thomsen, J, Caye-Thomasen, P. True incidence of vestibular schwannoma? Neurosurgery 2010;67:1335–40
13Harun, A, Agrawal, Y, Tan, M, Niparko, JK, Francis, HW. Sex and age associations with vestibular schwannoma size and presenting symptoms. Otol Neurotol 2012;33:1604–10
14Foley, RW, Shirazi, S, Maweni, RM, Walsh, K, McConn Walsh, R, Javadpour, M et al. Signs and symptoms of acoustic neuroma at initial presentation: an exploratory analysis. Cureus 2017;9:e1846
15British Acoustic Neuroma Association. About acoustic neuroma. In: [9 June 2018]
16Tos, M, Stangerup, SE, Cayé-Thomasen, P, Tos, T, Thomsen, J. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg 2004;130:216–20
17Ferri, GG, Modugno, GC, Pirodda, A, Fioravanti, A, Calbucci, F, Ceroni, AR. Conservative management of vestibular schwannomas: an effective strategy. Laryngoscope 2008;118:951–7
18Møller, MN, Hansen, S, Miyazaki, H, Stangerup, SE, Caye-Thomasen, P. Active treatment is not indicated in the majority of patients diagnosed with a vestibular schwannoma: a review on the natural history of hearing and tumor growth. Curr Otorhinolaryngol Rep 2014;2:242–7
19Moffat, DA, Kasbekar, A, Axon, PR, Lloyd, SK. Growth characteristics of vestibular schwannomas. Otol Neurotol 2012;33:1053–8
20Suryanarayanan, R, Ramsden, RT, Saeed, SR, Aggarwal, R, King, AT, Rutherford, SA et al. Vestibular schwannoma: role of conservative management. J Laryngol Otol 2010;124:251–7
21Mackeith, SA, Kerr, RS, Milford, CA. Trends in acoustic neuroma management: a 20-year review of the Oxford Skull Base Clinic. J Neurol Surg B Skull Base 2013;74:194200
22Younes, E, Montava, M, Bachelard-Serra, M, Jaloux, L, Salburgo, F, Lavieille, JP. Intracanalicular vestibular schwannomas: initial clinical manifestation, imaging classification, and risk stratification for management proposal. Otol Neurotol 2017;38:1345–50
23Martin, TP, Senthil, L, Chavda, SV, Walsh, R, Irving, RM. A protocol for the conservative management of vestibular schwannomas. Otol Neurotol 2009;30:381–5
24Escorihuela-García, V, Llópez-Carratalá, I, Orts-Alborch, M, Marco-Algarra, J. Clinical and radiological evolution of a group of untreated acoustic neuromas [in Spanish]. Acta Otorrinolaringol Esp 2014;65:219–24
25Fayad, JN, Semaan, MT, Lin, J, Berliner, KI, Brackmann, DE. Conservative management of vestibular schwannoma: expectations based on the length of the observation period. Otol Neurotol 2014;35:1258–65
26Reddy, CE, Lewis-Jones, HG, Javadpour, M, Ryland, I, Lesser, TH. Conservative management of vestibular schwannomas of 15 to 31 mm intracranial diameter. J Laryngol Otol 2014;128:752–8
27Hajioff, D, Raut, VV, Walsh, RM, Bath, AP, Bance, ML, Guha, A et al. Conservative management of vestibular schwannomas: third review of a 10-year prospective study. Clin Otolaryngol 2008;33:255–9
28Oddon, PA, Montava, M, Salburgo, F, Collin, M, Vercasson, C, Lavieille, JP. Conservative treatment of vestibular schwannoma: growth and Penn Acoustic Neuroma Quality of Life scale in French language. Acta Otorhinolaryngol Ital 2017;37:320–7
29Hughes, M, Skilbeck, C, Saeed, S, Bradford, R. Expectant management of vestibular schwannoma: a retrospective multivariate analysis of tumor growth and outcome. Skull Base 2011;21:295302
30Lee, JD, Park, MK, Kim, JS, Cho, YS. The factors associated with tumor stability observed with conservative management of intracanalicular vestibular schwannoma. Otol Neurotol 2014;35:918–21
31Whitehouse, K, Foroughi, M, Shone, G, Hatfield, R. Vestibular schwannomas – when should conservative management be reconsidered? Br J Neurosurg 2010;24:185–90
32Régis, J, Carron, R, Park, MC, Soumare, O, Delsanti, C, Thomassin, JM et al. Wait-and-see strategy compared with proactive Gamma Knife surgery in patients with intracanalicular vestibular schwannomas. J Neurosurg 2010;113(suppl):105–11
33Kirchmann, M, Karnov, K, Hansen, S, Dethloff, T, Stangerup, SE, Caye-Thomasen, P. Ten-year follow-up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma. Neurosurgery 2017;80:4956
34Varughese, JK, Breivik, CN, Wentzel-Larsen, T, Lund-Johansen, M. Growth of untreated vestibular schwannoma: a prospective study. J Neurosurg 2012;116:706–12
35Bakkouri, WE, Kania, RE, Guichard, JP, Lot, G, Herman, P, Huy, PT. Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. J Neurosurg 2009;110:662–9
36Ferri, GG, Pirodda, A, Ceroni, AR, Fioravanti, A, Calbucci, F, Modugno, GC. Management of growing vestibular schwannomas. Eur Arch Otorhinolaryngol 2013;270:2013–19
37Agrawal, Y, Clark, JH, Limb, CJ, Niparko, JK, Francis, HW. Predictors of vestibular schwannoma growth and clinical implications. Otol Neurotol 2010;31:807–12
38Eljamel, S, Hussain, M, Eljamel, MS. Should initial surveillance of vestibular schwannoma be abandoned? Skull Base 2011;21:5964
39Daultrey, CR, Rainsbury, JW, Irving, RM. Size as a risk factor for growth in conservatively managed vestibular schwannomas: the Birmingham experience. Otolaryngol Clin North Am 2016;49:1291–5
40Klersy, PC, Arlt, F, Hofer, M, Meixensberger, J. Quality of life in patients with unilateral vestibular schwannoma on wait and see - strategy. Neurol Res 2018;40:3440
41Nikolopoulos, TP, Fortnum, H, O'Donoghue, G, Baguley, D. Acoustic neuroma growth: a systematic review of the evidence. Otol Neurotol 2010;31:478–85
42Paldor, I, Chen, AS, Kaye, AH. Growth rate of vestibular schwannoma. J Clin Neurosci 2016;32:18
43Smouha, EE, Yoo, M, Mohr, K, Davis, RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope 2005;115:450–4
44Yamakami, I, Uchino, Y, Kobayashi, E, Yamaura, A. Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res 2003;25:682–90
45Yoshimoto, Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg 2005;103:5963
46Wilson, YL, Gandolfi, MM, Ahn, IE, Yu, G, Huang, TC, Kim, AH. Cost analysis of asymmetric sensorineural hearing loss investigations. Laryngoscope 2010;120:1832–6
47Pan, P, Huang, J, Morioka, C, Hathout, G, El-Saden, SM. Cost analysis of vestibular schwannoma screening with contrast-enhanced magnetic resonance imaging in patients with asymmetrical hearing loss. J Laryngol Otol 2016;130:21–4
48Choi, KJ, Sajisevi, MB, Kahmke, RR, Kaylie, DM. Incidence of retrocochlear pathology found on MRI in patients with non-pulsatile tinnitus. Otol Neurotol 2015;36:1730–4
49Newton, JR, Shakeel, M, Flatman, S, Beattie, C, Ram, B. Magnetic resonance imaging screening in acoustic neuroma. Am J Otolaryngol 2010;31:217–20
50Suzuki, M, Hashimoto, S, Kano, S, Okitsu, T. Prevalence of acoustic neuroma associated with each configuration of pure tone audiogram in patients with asymmetric sensorineural hearing loss. Ann Otol Rhinol Laryngol 2010;119:615–18
51Egan, CR. Asymmetric hearing loss stratification and vestibular schwannoma risk: a meta-analysis. In: [26 June 2018]
52Sweeney, AD, Carlson, ML, Shepard, NT, McCracken, DJ, Vivas, EX, Neff, BA et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines on otologic and audiologic screening for patients with vestibular schwannomas. Neurosurgery 2018;82:E2931
53Amiraraghi, N, Lim, S, Kontorinis, G. Findings on 7000 magnetic resonance scans of the internal auditory meatus: to scan or not to scan? J Laryngol Otol 2016;130:S82
54Aaron, KA, Gildener-Leapman, N, Trivedi, S, Reinstadler, DR, Zimmerman, SD, Casazza, GC et al. Cost effectiveness of vestibular schwannoma screening. Otolaryngol Head Neck Surg 2015;153:96
55Pena, I, Chew, EY, Landau, BP, Breen, JT, Zevallos, JP, Vrabec, JT. Diagnostic criteria for detection of vestibular schwannomas in the VA population. Otol Neurotol 2016;37:1510–15
56Rajeev, M, Babur, S, Karakitsou, M, Mehta, S. Audit of magnetic resonance imaging for vestibular schwannoma. Clin Otolaryngol 2012;37:63
57Hoekstra, CE, Prijs, VF, van Zanten, GA. Diagnostic yield of a routine magnetic resonance imaging in tinnitus and clinical relevance of the anterior inferior cerebellar artery loops. Otol Neurotol 2015;36:5965
58Carlson, ML, Lees, KA, Patel, NS, Loshe, CM, Neff, BA, Link, MJ et al. The clinical behaviour of asymptomatic, incidental vestibular schwannomas is similar to that of symptomatic tumours. Otol Neurotol 2016;37:1435–41
59Broomfield, SJ, O'Donoghue, GM. Self-reported symptoms and patient experience: a British Acoustic Neuroma Association survey. Br J Neurosurg 2016;30:294301
60Armstrong, R. Find out how much you cost the NHS. In: [17 July 2018]
61Carlson, ML, Tveiten, OV, Driscoll, CL, Goplen, FK, Neff, BA, Pollock, BE et al. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg 2015;122:833–42
62Stangerup, S-E, Caye-Thomasen, P, Høstmark, K. Life expectancy after diagnosis of vestibular schwannoma in patients age 70 years or older. J Neurol Surg B 2012;73:A226
63Soulier, G, van Leeuwen, BM, Putter, H, Jansen, JC, Malessy, MJA, van Benthem, PPG et al. Quality of life in 807 patients with vestibular schwannoma: comparing treatment modalities. Otolaryngol Head Neck Surg 2017;157:92–8
64Vernooji, MW, Ikram, MA, Tanghe, HL, Vincent, A, Hofman, A, Krestin, GP et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357:1281–8


Screening for vestibular schwannoma in the context of an ageing population

  • S Basu (a1), R Youngs (a1) and A Mitchell-Innes (a2)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed